Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.57 |
| ▸ | CAMKK2 | Q96RR4 | 14/20 | 0.50 |
| ▸ | ACMSD | Q8TDX5 | 2/20 | 0.47 |
| ▸ | ABCC1 | P33527 | 1/20 | 0.47 |
| ▸ | CAMKK1 | Q8N5S9 | 9/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16421197 | 0.91 | CSNK2A1 (0.48) | PTGDR2CAMKK2ABCC1CAMKK1CSNK2A1 | |
| SCHEMBL30410929 | 0.91 | CSNK2A1 (0.48) | PTGDR2CAMKK2ABCC1CAMKK1CSNK2A1 | |
| SCHEMBL27652147 | 0.88 | PTGDR2 (0.55) | PTGDR2CAMKK2ACMSDABCC1NPC1 | |
| SCHEMBL5728643 | 0.85 | PTGDR2 (0.51) | PTGDR2CAMKK2CAMKK1NPC1RAB9A | |
| SCHEMBL1925577 | 0.85 | CSNK2A1 (0.46) | PTGDR2CAMKK2ACMSDABCC1NPC1 | |
| SCHEMBL27832639 | 0.83 | PTGDR2 (0.53) | PTGDR2NPC1RAB9A | |
| SCHEMBL9220646 | 0.83 | PTGDR2 (0.50) | PTGDR2NPC1RAB9A | |
| Methyl Alcohol SCHEMBL31596316 | 0.82 | KMO (0.51) | CAMKK2ACMSDCAMKK1 | |
| SCHEMBL3443366 | 0.81 | ACMSD (0.53) | CAMKK2ACMSDCAMKK1 | |
| SCHEMBL448284 | 0.81 | KMO (0.54) | CAMKK2ACMSDCAMKK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3307395-B1 | SOLUBILISING AGENTS FOR UV SCREENING COMPOUNDS | ISP INVESTMENTS LLC (US) | 2020-08-05 | — | — | EP | disclosed |
| CN-111362787-A | Synthesis method of trans-4-alkyl cyclohexyl benzoic acid | 惠泽化学科技(濮阳)有限公司 | 2020-07-03 | — | — | CN | disclosed |
| US-10328003-B2 | Solubilizing agents for active or functional organic compounds | ISP INVESTMENTS LLC (US) | 2019-06-25 | — | — | US | disclosed |
| US-20180168970-A1 | SOLUBILIZING AGENTS FOR ACTIVE OR FUNCTIONAL ORGANIC COMPOUNDS | ISP INVESTMENTS LLC (US) | 2018-06-21 | — | — | US | disclosed |
| EP-3307395-A1 | SOLUBILIZING AGENTS FOR FUNCTIONAL ACTIVE COMPOUNDS | ISP Investments LLC (US) | 2018-04-18 | — | — | EP | disclosed |
| WO-2016201260-A1 | SOLUBILIZING AGENTS FOR FUNCTIONAL ACTIVE COMPOUNDS | ISP INVESTMENTS INC. (US) | 2016-12-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10328003-B2 | Solubilizing agents for active or functional organic compounds | C1S, POLR1C, TYR | PTGDR2 1592/4885CAMKK2 3871/4885ACMSD 943/4885 |
| US-20180168970-A1 | SOLUBILIZING AGENTS FOR ACTIVE OR FUNCTIONAL ORGANIC COMPOUNDS | C1S, POLR1C, TYR | PTGDR2 1592/4885CAMKK2 3871/4885ACMSD 943/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.